{
  "variant_id": {
    "Gene": "EGFR",
    "Protein_Change": {
      "ref": "L",
      "alt": "R",
      "position": "858"
    },
    "variant_string_id": "EGFR L858R"
  },
  "functional_evidence_aim": "Pathogenic",
  "assessment_steps": [
    {
      "step_name": "Step 1: Define the disease mechanism",
      "extracted_paper_info": "The EGFR L858R mutation contributes to NSCLC pathogenesis by promoting oncogenic signaling.",
      "judgment": "Yes"
    },
    {
      "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
      "extracted_paper_info": "A protein interaction assay is a relevant and appropriate method to study the molecular consequences of the EGFR L858R mutation.",
      "judgment": "Yes"
    },
    {
      "step_name": "Step 3: Evaluate validity of specific instances of assays",
      "extracted_paper_info": "The paper includes variant controls for the EGFR L858R mutation, using known pathogenic variants as positive controls and benign variants as negative controls.",
      "judgment": "Yes"
    },
    {
      "step_name": "Step 4: Apply evidence to individual variant interpretation",
      "extracted_paper_info": "The OddsPath value for the EGFR L858R mutation is approximately 15.6, which falls within the moderate category according to ACMG guidelines.",
      "judgment": "Yes"
    }
  ],
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3_supporting"
  },
  "overall_conclusion": "The EGFR L858R mutation is associated with NSCLC pathogenesis and shows moderate evidence of being pathogenic, as indicated by an OddsPath value of approximately 15.6."
}